We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$238M
AUM Growth
+$25.7M
Cap. Flow
+$5.05M
Cap. Flow %
2.13%
Top 10 Hldgs %
35.47%
Holding
116
New
16
Increased
25
Reduced
31
Closed
25

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$5.97M
2
TJX icon
TJX Companies
TJX
+$4.98M
3
PFE icon
Pfizer
PFE
+$4.01M
4
CB icon
Chubb
CB
+$2.74M
5
PG icon
Procter & Gamble
PG
+$2.64M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.34M
2
WRB icon
W.R. Berkley
WRB
+$3.36M
3
DLTR icon
Dollar Tree
DLTR
+$3.31M
4
RF icon
Regions Financial
RF
+$2.99M
5
KDP icon
Keurig Dr Pepper
KDP
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 30.3%
2 Financials 12.53%
3 Healthcare 12.28%
4 Consumer Discretionary 9.74%
5 Industrials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
D icon
76
Dominion Energy
D
$59.5B
$555K 0.23%
11,809
-25,354
-68% -$1.13M
LNG icon
77
Cheniere Energy
LNG
$55.2B
$496K 0.21%
2,906
– –
ANET icon
78
Arista Networks
ANET
$247B
$460K 0.19%
7,820
– –
FMC icon
79
FMC
FMC
$1.31B
$460K 0.19%
7,297
+3,476
+91% +$202K
COP icon
80
ConocoPhillips
COP
$151B
$375K 0.16%
3,232
– –
FITB
81
Fifth Third Bancorp
FITB
$52.2B
$352K 0.15%
10,197
– –
FDX icon
82
FedEx
FDX
$76.2B
$349K 0.15%
1,380
– –
SHEL icon
83
Shell
SHEL
$250B
$339K 0.14%
5,145
– –
MCHP icon
84
Microchip Technology
MCHP
$44.3B
$310K 0.13%
3,441
-28
-0.8% -$2.28K
FANG icon
85
Diamondback Energy
FANG
$56.6B
$293K 0.12%
1,889
-1,062
-36% -$166K
UCTT
86
Ultra Clean Holdings
UCTT
$3.78B
$202K 0.09%
+5,920
New +$165K
INFN
87
DELISTED
Infinera Corporation Common Stock
INFN
$88K 0.04%
18,465
– –
ESPR
88
DELISTED
Esperion Therapeutics
ESPR
$87K 0.04%
29,256
– –
VISN
89
Vistance Networks Inc
VISN
$2.68B
$67K 0.03%
23,813
+5,553
+30% +$12K
ORGO icon
90
Organogenesis Holdings
ORGO
$237M
$54K 0.02%
13,303
– –
PGEN icon
91
Precigen
PGEN
$2.48B
$23K 0.01%
17,373
– –
ADI icon
92
Analog Devices
ADI
$188B
– –
-5,287
Closed -$926K
ALB icon
93
Albemarle
ALB
$15.3B
– –
-5,262
Closed -$895K
APA icon
94
APA Corp
APA
$14.3B
– –
-9,114
Closed -$375K
CSX icon
95
CSX Corp
CSX
$92.4B
– –
-14,176
Closed -$436K
CVS icon
96
CVS Health
CVS
$119B
– –
-90,806
Closed -$6.34M
DG icon
97
Dollar General
DG
$26.7B
– –
-3,594
Closed -$380K
DLTR icon
98
Dollar Tree
DLTR
$24.5B
– –
-31,081
Closed -$3.31M
ELAN icon
99
Elanco Animal Health
ELAN
$11.4B
– –
-42,877
Closed -$482K
EW icon
100
Edwards Lifesciences
EW
$53.6B
– –
-23,706
Closed -$1.64M
1 2 3
4
5

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
FA
FSA Advisors Troy, Michigan $152M AUM 16.73% 1-Year Est. Return

Stoneridge Investment Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Stoneridge Investment Partners held 116 positions worth $238M, up 12% from $212M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stoneridge Investment Partners's Q4 2023 filing shows 16 new, 25 increased, 31 reduced and 25 closed positions. Its largest new stake was Biogen: 24,322 shares worth $6.29M. The largest sale was CVS Health, an estimated $6.34M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

  • Stoneridge Investment Partners's largest Q4 2023 buy was Biogen: 24,322 shares worth $6.29M.
  • Stoneridge Investment Partners added most to Pfizer in Q4 2023, an estimated $4.01M increase.
  • Stoneridge Investment Partners's biggest Q4 2023 reduction was Salesforce, cutting an estimated $2.42M.
  • Stoneridge Investment Partners fully exited CVS Health in Q4 2023, selling an estimated $6.34M.
  • Stoneridge Investment Partners's ten largest holdings make up 35% of its $238M portfolio in Q4 2023.
  • Stoneridge Investment Partners opened 16 new positions and closed 25 in Q4 2023.
  • Stoneridge Investment Partners's portfolio value rose 12% quarter-over-quarter to $238M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2023, filed 7 Feb 2024.